Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
How tirzepatide works: Activates GLP-1 and GIP pathways Enhances insulin response Strongly suppresses appetite Improves energy metabolism Benefits of tirzepatide include: Greater weight loss potential compared to GLP-1 alone Improved blood sugar regulation Enhanced fat metabolism Long-lasting appetite control Many patients who do not respond fully to semaglutide may benefit from tirzepatide due to its dual mechanism
Retatrutide (LY3437943) is a once-weekly injection that activates three different hormone receptors at the same time: GLP-1 (Glucagon-Like Peptide-1) receptor - controls blood sugar and appetite GIP (Glucose-Dependent Insulinotropic Polypeptide) receptor - enhances insulin release and metabolism Glucagon receptor - increases energy expenditure and fat burning Think of it like this: Semaglutide (Ozempic) = Single agonist (GLP-1 only) Tirzepatide (Mounjaro) = Dual agonist (GLP-1 + GIP) Retatrutide = Triple agonist (GLP-1 + GIP + Glucagon) Each added receptor appears to amplify the benefits
This suggests that pharmaceutical weight loss creates a somewhat steeper rebound trajectory compared to lifestyle-only approaches, reinforcing the importance of maintaining strong nutritional foundations regardless of medication status
Its growing relevance in scientific studies reflects the increasing demand for compounds that allow broader and more integrated metabolic research
Here's how the numbers work out: That 12-month commitment saves you nearly $25 per month compared to the shortest option
US$ 26.31
US$ 26.44
US$ 20.32
